NBY has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
NBY has been removed from your Stock Email Alerts list.
| Company | NovaBay Pharmaceuticals, Inc. (NBY) | () |
| Number of Guru Holders | ||
| Combined Weightings (%) | ||
| Number of Guru Buys:Sells (3 months) | 0 : 0 | 0 : 0 |
| Number of Guru Buys:Sells (6 months) | 0 : 0 | 0 : 0 |
| Number of Guru Buys:Sells (12 months) | 0 : 0 | 0 : 0 |
| Number of Insider Buys (3 months) | 1 | |
| Industry | Drug Manufacturers - Specialty & Generic | |
| Price ($) | 1.41 | |
| Market Value ($mil) | 52.26 | |
| Revenue ($mil) | 6.65 | |
| P/E(ttm) | 0 | |
| P/S | 6.41 | |
| P/B | 3.69 | |
| Yield (%) | 0 | |
| Payout | 0 | |
| ROA (%) | -36.50 | |
| ROE (%) | -50 | |
| Operating Margin (%) | -119.60 | |
| Net Margin (%) | -101.20 | |
| Debt to Equity (%) | 0 | |
| 10-Year Rvn. Growth (%) | 0 | |
| 10-Year Earning Growth (%) | 0 | |
| 5-Year Rvn. Growth (%) | -9.80 | |
| 5-Year Earning Growth (%) | 0 | |
| 1-Year Rvn. Growth (%) | -42.10 | |
| 1-Year Earning Growth (%) | 0 |